Treatment status and progress of laryngopharyngeal reflux disease.
10.13201/j.issn.2096-7993.2025.05.019
- Author:
Junjie YANG
1
;
Duojie BIANBA
2
;
Shenwei XIE
3
;
Di JI
1
;
Yi ZHANG
1
;
Anchun DENG
1
Author Information
1. Department of Otolaryngology Head and Neck Surgery，the Second Affiliated Hospital of Army Medical University，Chongqing，400037，China.
2. Department of Otolaryngology Head and Neck Surgery，953 Hospital of PLA Army.
3. Department of Health Management Recearch Center，953 Hospital of PLA Army.
- Publication Type:Journal Article
- Keywords:
aryngopharyngeal reflux disease;
progress;
proton pump inhibitors;
treatment
- MeSH:
Humans;
Laryngopharyngeal Reflux/therapy*;
Proton Pump Inhibitors/therapeutic use*
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(5):491-495
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Laryngopharyngeal reflux disease refers to a series of symptoms and signs caused by gastroduodenal contents regurgitate into the upper respiratory, digestive tract above the upper esophageal sphincter. In recent years, with the deepening of the pathogenesis, the treatment plan of this disease is constantly updated and optimized, but there is still no gold standard for treatment. This paper summarizes the treatment of pharyngeal reflux disease and proposes that based on proton pump inhibitors, potassium competitive acid blockers and alginate can be used as alternative therapy for proton pump inhibitors. Meanwhile, the external upper esophageal sphincter pressure device has sufficient potential value to be concerned. Lifestyle change and dietary structure adjustment should be used as the basic treatment throughout. To provide directions for further treatment of the disease.
